Inspiration from Google’s Multi-Layer AI
In this episode, we draw inspiration from Google’s innovative multi-layer AI strategy unveiled at Cloud Next. Join us to explore the creative angles that emerge from this strategy. See Privacy Policy...
22 Apr 16min
New Apple CEO, OpenAI's New Image Model, Vercel AI Hack
In this episode, we explore the significant leadership change at Apple as Tim Cook steps down and John Tarnas takes the helm, amid ongoing challenges in the AI sector. We also discuss major developmen...
21 Apr 16min
Anthropic Surpasses OpenAI: A Financial Update
In this episode, we provide an update on how Anthropic has surpassed OpenAI in revenue. Join us for an analysis of what this means moving forward. See Privacy Policy at https://art19.com/privacy and ...
20 Apr 14min
Claude’s Design and Its Market Opportunities
In this episode, we analyze the market opportunities presented by Claude’s design. Understand how businesses can leverage AI advancements. See Privacy Policy at https://art19.com/privacy and Californ...
17 Apr 14min
Anthropic Ships Opus 4.7, $2B With No Product & Google AI Deals
Anthropic dropped Claude Opus 4.7 today, but the bigger story is the model they didn't release. We break down Project Glasswing, why Mythos stays locked up, and what it signals about where frontier AI...
16 Apr 14min
Anthropic's IPO Play, Novo Nordisk x OpenAI, and the First Brain Sensor Goes Human
Anthropic adds the Novartis CEO to its board as it gears up for an IPO — and on the same day, Novo Nordisk partners with OpenAI to supercharge drug development. We break down what this healthcare AI l...
15 Apr 15min
Altman Gets Molotov Cocktail, Zuckerberg Creates AI Clone
In this episode, we explore groundbreaking developments in the tech world, including Mark Zuckerberg's creation of an AI version of himself and Apple's revolutionary smart glasses. We also discuss the...
13 Apr 15min
Meta's New Model, Gemini 4, OpenAI Proposes AI Policy
Today we (really just me lol) talk about Google's launch of Gemini 4, a groundbreaking open-source model. We also discuss the implications of Eli Lilly's powerful new supercomputer for drug developmen...
9 Apr 15min
